While some might consider craft beer the commercialization of innovative biotechnology (we do!), we’re more excited about the emerging pharma—the bad ass biotechs in pre-clinical and clinical development.
So, you be you.
As rare disease and orphan drugs take center stage, we’re only going to see more activity in this busy market. Which is awesome for creating better therapies, real cures and healthy humans. At the same time, a lot of market noise in an increasingly scientific landscape can pose challenges. But not for us.
We’ve got the proverbial “it” factor. So, you be you. Focus on trials, establishing partnerships, preparing for IPOs, dealing with the Feds. We’ll focus on getting you noticed and keeping all your constituents educated and informed through strategic and tactical marketing communication.